NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 126 filers reported holding NUVATION BIO INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $279,000 | – | 29,982 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 15,072,340 | $28,938,893 | 9.75% |
| Aisling Capital Management LP | 2,541,009 | $4,878,737 | 3.22% |
| EDBI Pte Ltd | 1,270,504 | $2,439,368 | 3.11% |
| EcoR1 Capital, LLC | 13,896,543 | $26,681,363 | 0.81% |
| Deep Track Capital, LP | 8,221,188 | $15,784,681 | 0.66% |
| AlphaCentric Advisors LLC | 325,000 | $624,000 | 0.62% |
| 683 Capital Management, LLC | 2,500,000 | $4,799,999 | 0.41% |
| BRAIDWELL LP | 4,122,900 | $7,915,968 | 0.26% |
| Abrams Capital Management | 3,811,513 | $7,318,105 | 0.26% |
| Redmile Group, LLC | 3,031,009 | $5,819,537 | 0.24% |